Melatonin modulates permeability transition pore and 5-hydroxydecanoate induced K-ATP channel inhibition in isolated brain mitochondria

作者：Waseem Mohammad; Tabassum Heena; Parvez Suhel^*

来源：Mitochondrion, 2016, 31: 1-8.

DOI：10.1016/j.mito.2016.08.005

• Mitochondria
• K-ATP channels
• 5-Hydroxydecanoate
• Permeability transition pore
• Melatonin
• Oxidative stress

There is increasing recognition of the magnitude of mitochondria in neurodegenerative disorders. Mitochondria play a key role in apoptotic and necrotic cell death. Melatonin (Mel), an indoleamine produced in several organs including the pineal gland has been known for its neuroprotective actions. In our study, we have investigated whether the mitochondrial ATP sensitive potassium (mtK(ATP)) channel blocker 5-hydroxydecanoate (5-HD) and calcium (Ca2+) affects permeability transition pore (PTP) alterations in isolated brain mitochondria treated with melatonin (Mel) and cyclosporin A (CsA). Mitochondrial swelling, mitochondrial membrane potential (Delta psi(m)), ROS measurement and mitochondrial respiration were evaluated in isolated brain mitochondria. In our results, mitochondrial swelling stimulated by exposing Ca2+ ions and 5-HD associated by mPTP opening as depicted by modulation of CsA and Mel. In addition, Ca2+ and 5-HD decreased Delta psi(m), depleted intracellular ROS, and inhibition of mitochondria( respiration (state 3 and state 4) in isolated brain mitochondria. Addition of Mel and CsA has shown significant restoration in mitochondrial swelling, Delta psi(m), intracellular ROS measurement and mitochondrial respiration in isolated brain mitochondria. Therefore, we speculate the modulatory effect of Mel and CsA in mitochondria treated with 5-HD and Ca2+ hinders the mPTP-mediated mitochondrial dysfunction and cellular oxidative stress. We conclude that inhibition of mPT is one likely mechanism of CsA's and its neuroprotective actions. Development of neuroprotective agents including Mel targeting the mPTP therefore bears hope for future treatment of severe neurodegenerative diseases.

• 出版日期2016-11